Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents.

Patil AA, Sayal P, Depondt ML, Beveridge RD, Roylance A, Kriplani DH, Myers KN, Cox A, Jellinek D, Fernando M, Carroll TA, Collis SJ.

Oncotarget. 2014 Aug 15;5(15):6414-24.

2.

Lymphoblastic leukaemia presenting as a carotid-cavernous fistula.

Bagga V, Yapa S, Craven I, Romanowski C, Jellinek D.

Neuroradiol J. 2013 Feb;26(1):94-6. Epub 2013 Mar 8.

3.

Focal cortical dysplasia mimicking neoplasia.

Bahl A, Romanowski CA, Ince PG, McKevitt FM, Jellinek DA.

Pract Neurol. 2013 Oct;13(5):343-5. doi: 10.1136/practneurol-2012-000317. Epub 2013 Mar 15. No abstract available.

PMID:
23504031
4.

A pilot study to measure marks in children with cerebral palsy using a novel measurement template.

Bennett T, Jellinek D, Bennett M.

Child Care Health Dev. 2013 Nov;39(6):864-8. doi: 10.1111/j.1365-2214.2012.01419.x. Epub 2012 Aug 15.

5.

Diffuse leptomeningeal spread of pleomorphic xanthoastrocytoma.

McLean CA, Jellinek DA, Gonzales MF.

J Clin Neurosci. 1998 Apr;5(2):230-3.

PMID:
18639021
6.

A case of pneumocephalus secondary to VP shunt in a patient with acoustic neuroma.

Jellinek DA, Briggs RJ, Mitchell PJ.

J Clin Neurosci. 1998 Apr;5(2):226-8.

PMID:
18639019
7.

Subtypes of oligodendroglioma defined by 1p,19q deletions, differ in the proportion of apoptotic cells but not in replication-licensed non-proliferating cells.

Wharton SB, Maltby E, Jellinek DA, Levy D, Atkey N, Hibberd S, Crimmins D, Stoeber K, Williams GH.

Acta Neuropathol. 2007 Feb;113(2):119-27. Epub 2006 Dec 9.

8.

Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma.

Chen YJ, Hakin-Smith V, Teo M, Xinarianos GE, Jellinek DA, Carroll T, McDowell D, MacFarlane MR, Boet R, Baguley BC, Braithwaite AW, Reddel RR, Royds JA.

Cancer Res. 2006 Jul 1;66(13):6473-6.

9.

Extra-cranial metastasis of glioblastoma multiforme presenting as acute parotitis.

Taha M, Ahmad A, Wharton S, Jellinek D.

Br J Neurosurg. 2005 Aug;19(4):348-51.

PMID:
16455543
10.

A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.

Henson JD, Hannay JA, McCarthy SW, Royds JA, Yeager TR, Robinson RA, Wharton SB, Jellinek DA, Arbuckle SM, Yoo J, Robinson BG, Learoyd DL, Stalley PD, Bonar SF, Yu D, Pollock RE, Reddel RR.

Clin Cancer Res. 2005 Jan 1;11(1):217-25.

11.

DNA replication licensing and cell cycle kinetics of oligodendroglial tumours.

Wharton SB, Hibberd S, Eward KL, Crimmins D, Jellinek DA, Levy D, Stoeber K, Williams GH.

Br J Cancer. 2004 Jul 19;91(2):262-9.

12.

Mammalian stanniocalcins and cancer.

Chang AC, Jellinek DA, Reddel RR.

Endocr Relat Cancer. 2003 Sep;10(3):359-73. Review.

PMID:
14503913
13.

Motor functional MRI for pre-operative and intraoperative neurosurgical guidance.

Wilkinson ID, Romanowski CA, Jellinek DA, Morris J, Griffiths PD.

Br J Radiol. 2003 Feb;76(902):98-103.

PMID:
12642277
14.

Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme.

Hakin-Smith V, Jellinek DA, Levy D, Carroll T, Teo M, Timperley WR, McKay MJ, Reddel RR, Royds JA.

Lancet. 2003 Mar 8;361(9360):836-8.

PMID:
12642053
15.

Multimodality MR imaging depiction of hemodynamic changes and cerebral ischemia in subarachnoid hemorrhage.

Griffiths PD, Wilkinson ID, Mitchell P, Patel MC, Paley MN, Romanowski CA, Powell T, Hodgson TJ, Hoggard N, Jellinek D.

AJNR Am J Neuroradiol. 2001 Oct;22(9):1690-7.

16.

Detection of subarachnoid haemorrhage with magnetic resonance imaging.

Mitchell P, Wilkinson ID, Hoggard N, Paley MN, Jellinek DA, Powell T, Romanowski C, Hodgson T, Griffiths PD.

J Neurol Neurosurg Psychiatry. 2001 Feb;70(2):205-11.

17.

Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells.

Jellinek DA, Chang AC, Larsen MR, Wang X, Robinson PJ, Reddel RR.

Biochem J. 2000 Sep 1;350 Pt 2:453-61.

18.

Aneurysmal bone cyst of the orbit: a case report and review of literature.

Menon J, Brosnahan DM, Jellinek DA.

Eye (Lond). 1999 Dec;13 ( Pt 6):764-8. Review.

PMID:
10707141
19.

Expression and localisation of stanniocalcin 1 in rat bladder, kidney and ovary.

Worthington RA, Brown L, Jellinek D, Chang AC, Reddel RR, Hambly BD, Barden JA.

Electrophoresis. 1999 Jul;20(10):2071-6.

PMID:
10451117
20.

Meningiomas, dicentric chromosomes, gliomas, and telomerase activity.

Carroll T, Maltby E, Brock I, Royds J, Timperley W, Jellinek D.

J Pathol. 1999 Aug;188(4):395-9.

PMID:
10440750
21.

Subarachnoid hemorrhage due to late recurrence of a previously unruptured aneurysm after complete endovascular occlusion.

Hodgson TJ, Carroll T, Jellinek DA.

AJNR Am J Neuroradiol. 1998 Nov-Dec;19(10):1939-41.

22.

Potent 2'-amino-, and 2'-fluoro-2'-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor.

Pagratis NC, Bell C, Chang YF, Jennings S, Fitzwater T, Jellinek D, Dang C.

Nat Biotechnol. 1997 Jan;15(1):68-73.

PMID:
9035109
23.

Inhibitory DNA ligands to platelet-derived growth factor B-chain.

Green LS, Jellinek D, Jenison R, Ostman A, Heldin CH, Janjic N.

Biochemistry. 1996 Nov 12;35(45):14413-24.

PMID:
8916928
24.

Needs of disabled children and their families.

Milner J, Bungay C, Jellinek D, Hall DM.

Arch Dis Child. 1996 Nov;75(5):399-404.

25.

Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor.

Green LS, Jellinek D, Bell C, Beebe LA, Feistner BD, Gill SC, Jucker FM, Janjić N.

Chem Biol. 1995 Oct;2(10):683-95.

26.

Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor.

Jellinek D, Green LS, Bell C, Lynott CK, Gill N, Vargeese C, Kirschenheuter G, McGee DP, Abesinghe P, Pieken WA, et al.

Biochemistry. 1995 Sep 12;34(36):11363-72.

PMID:
7547864
27.

How are children's growth problems diagnosed?

Jellinek D, Hall DM.

Child Care Health Dev. 1994 Nov-Dec;20(6):371-7.

PMID:
7842493
28.

Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor.

Jellinek D, Green LS, Bell C, Janjić N.

Biochemistry. 1994 Aug 30;33(34):10450-6.

PMID:
7520755
29.

Effect of three different surgical prone positions on lung volumes in healthy volunteers.

Mahajan RP, Hennessy N, Aitkenhead AR, Jellinek D.

Anaesthesia. 1994 Jul;49(7):583-6.

30.

High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding.

Jellinek D, Lynott CK, Rifkin DB, Janjić N.

Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11227-31.

31.

Electrical stimulation of motor cortex in experimental cortical ischaemia: pyramidal responses at C5 and the surface EMG.

Liu X, Branston NM, Kawauchi M, Jellinek DA, Symon L.

Electroencephalogr Clin Neurophysiol. 1992 Jun;85(3):209-14.

PMID:
1376679
32.

The role of motor evoked potentials in the management of hysterical paraplegia: case report.

Jellinek DA, Bradford R, Bailey I, Symon L.

Paraplegia. 1992 Apr;30(4):300-2.

35.

Separation of growth-promoting activity for human muscle cells from fetuin.

Nie Z, Jellinek D, Ham RG.

Biochem Biophys Res Commun. 1991 Aug 15;178(3):959-66.

PMID:
1714728
36.
37.

Visiting and immunisation policies on a regional neonatal unit.

Blake KD, Jellinek DC.

Lancet. 1990 Aug 4;336(8710):308-9. No abstract available.

PMID:
1973989

Supplemental Content

Loading ...
Support Center